IceCure Medical Ltd (ICCM) Fair Value 2026

ICCM · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.8 /10

32 fundamental signals · 0 models active

Value Trap Risk

DANGER (80/100)

Quick Summary — As of 2026-08-28, IceCure Medical Ltd (ICCM) trades at $2.30. QOC: 2.8/10. Value Trap Risk: 80/100 (DANGER). 0/13 models active.

Key Facts

Ticker
ICCM
Price
$2.30
Quality Score
2.8/10
Value Trap Risk
80/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 80 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give ICCM?

0 Intrinsic Value Models vs. Current Price ($2.30)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is IceCure Medical Ltd (ICCM) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, IceCure Medical Ltd currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About ICCM?

0 of 13 models are currently active for ICCM. See which stocks rank higher →

How Does ICCM Rank in Medical Devices?

Among 159 Medical Devices stocks, ICCM ranks #156 by Quality of Company score. CirclFi's QOC score of 2.8/10 evaluates 32 fundamental signals. A score of 2.8 signals below-average fundamentals.

See all Most Undervalued Medical Devices Stocks →

IceCure Medical Ltd's positioning within the Medical Devices segment means that FDA approval probability plays an outsized role in fundamental analysis. The sector's unique characteristics — including regulatory pathway clarity — shape both the opportunity set and risk profile.

Is ICCM a Value Trap?

CirclFi's Value Trap algorithm assigns ICCM a score of 80/100 (DANGER). This is a high-risk signal. Deteriorating fundamentals suggest the discount may be justified. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for IceCure Medical Ltd. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, IceCure Medical Ltd earns a quality score of 2.8/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. However, our Value Trap algorithm flags elevated risk — suggesting that apparent cheapness may mask deteriorating fundamentals.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ICCM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy IceCure Medical Ltd Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

WOKWORK Medical Technology Group LTDQOC 2.8BDMDBaird Medical Investment Holdings LimitedQOC 2.8RTGNRetinalGenix Technologies Inc.QOC 3.5BWAYBrainsWay Ltd.QOC 2.6LMRILumexa Imaging Holdings, Inc.QOC 3.5ITOCiTonic Holdings Ltd.QOC 2.5DCTHDelcath Systems, Inc.QOC 7.4ECORelectroCore, Inc.QOC 6.4QSIQuantum-Si incorporatedQOC 5.4IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: WOK · BDMD · RTGN · BWAY · LMRI · ITOC · DCTH · ECOR · QSI · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to ICCM?

7 companies across all industries closest to ICCM’s Quality of Company score of 2.8/10.

SBSafe Bulkers, Inc.QOC 2.8YDESYD Bio LtdQOC 2.8ZJKZJK Industrial Co., Ltd.QOC 2.8IZMICZOOM Group Inc.QOC 2.8KNRXKnorex Ltd.QOC 2.8UFGUni-Fuels Holdings LimitedQOC 2.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SB · YDES · ZJK · IZM · KNRX · UFG · NVDA

Where Does ICCM Sit in CirclFi's Medical Devices Rankings?

ICCM is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About IceCure Medical Ltd’s Valuation?

What is IceCure Medical Ltd's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for IceCure Medical Ltd (ICCM). The Quality of Company score is 2.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ICCM overvalued or undervalued right now?

At $2.30, 0 of 0 active models suggest ICCM may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits IceCure Medical Ltd's business model in Medical Devices.

What does a Quality of Company score of 2.8 mean for ICCM?

IceCure Medical Ltd's QOC of 2.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on ICCM?

CirclFi analyzes ICCM with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is ICCM a value trap in 2026?

IceCure Medical Ltd's Value Trap score is 80/100 (DANGER). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns IceCure Medical Ltd (ICCM) a Quality of Company score of 2.8/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/ICCM/ · Methodology
Primary sources for this ICCM valuation
  • Financial statements: IceCure Medical Ltd 10-K and 10-Q filings on SEC EDGAR (CIK 0001584371) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ICCM as of ; valuations recomputed .